Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go?

With an increased understanding of the tumor biology of squamous cell carcinoma of the head and neck (SCCHN), targeted therapies have found their way into the clinical treatment routines against this entity. Nevertheless, to date platinum-based cytostatic agents remain the first line choice and targ...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancers (Basel)
Hoofdauteurs: von der Grün, Jens, Rödel, Franz, Brandts, Christian, Fokas, Emmanouil, Guckenberger, Matthias, Rödel, Claus, Balermpas, Panagiotis
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2019
Onderwerpen:
Review
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6521064/
https://ncbi.nlm.nih.gov/pubmed/30987257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11040472
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items